Cardiac prosthesis as an advanced surgical therapy for end-stage cardiac patients: Current status and future perspectives

Journal of Medical and Dental Sciences

Volumn 47, Issue 3, 2000, Pages 151-165

  Takatani, Setsuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Gene therapy; Heart transplantation; Total artificial heart (TAH); Ventricular assist device (VAD)

Indexed keywords

BIOMATERIAL;

ANIMAL; ARTIFICIAL HEART PACEMAKER; ASSISTED CIRCULATION; BIOTECHNOLOGY; BLOOD RHEOLOGY; CHEMISTRY; CONGESTIVE HEART FAILURE; FORECASTING; HEART ASSIST DEVICE; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; INFECTION; PROSTHESIS; PULSATILE FLOW; REVIEW; SURVIVAL RATE; THROMBOEMBOLISM;

ANIMALS; ASSISTED CIRCULATION; BIOCOMPATIBLE MATERIALS; BIOTECHNOLOGY; CARDIAC SURGICAL PROCEDURES; FORECASTING; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART, ARTIFICIAL; HEART-ASSIST DEVICES; HEMORHEOLOGY; HUMANS; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; PULSATILE FLOW; SURVIVAL RATE; THROMBOEMBOLISM;

EID: 0034261568     PISSN: 13428810     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Akutsu T, Kolff WJ. Permanent substitutes for valves and hearts. Trans Am Soc Artif Intern Organs 1957;4:230.
2. DeBakey ME. Left ventricular bypass pump for cardiac assistance. Clinical experiences. Am J Cardiol 1971;27:3-11.
3. Hogness JR, VanAntwerp M. The artificial heart. Prototypes, policies, and patients. National Academy Press, Washington, DC, 1991.
4. Cooley DA, Liota D, Hallman GL, et al. Orthotopic cardiac prosthesis for 2-stage cardiac replacement. Am J Cardiol 1969;24:723-730.
5. Murakami T, Ozawa K, Harasaki H, et al. Transient and permanent problems associated with the total artificial heart implantation. Trans Am Soc Artif Intern Organs 1979;25:239-248.
6. Kasai S, Koshino I, Washizu T, et al. Survival for 145 days with a total artificial heart. J Thorac Cardiovasc Surg 1977;73:637.
7. Jarvik RK, Smith LM, Lawson JH, et al. Comparison of pneumatic and electrically powered total artificial hearts in vivo. Trans Am Soc Artif Intern Organs 1978;24:593.
8. Honda K, Kito Y, Gibson W, et al. Lung problem and liver damage in total artificial heart and their prevention. Trans Am Soc Artif Intern Organs 1974;20A:27.
9. Atsumi K, Sakurai Y, Fujimasa I, et al. Hemodynamic analysis on prolonged survival cases (30 days and 20 days) of artificial total heart replacement. Trans Am Soc Artif Intern Organs 1975;21:545.
10. Pierce WS, Brighton JA, Donachy JH, et al. The artificial heart, progress and promise. Arch Surg 1977;112:1430.
11. Hennig, W, Grosse-Siestrup, et al. The relationship of cardiac output and venous pressure in long surviving calves with total artificial heart. Trans Am Soc Artif Intern Organs 1978;24:616.
12. Johnston GG, Hammill FH, Johansen H, et al. Prolonged pulseless perfusion in unanesthetized calves. Arch Surg 1976:111:1225-1230.
13. Johnston GG, Hammill K, Johansen H, et al. Prolonged pulsatile and nonpulsatile LV bypass with a centrifugal pump. Trans ASAIO 1976;22:323-331.
14. Golding LR, Jacobs G, Murakami T, et al. Chronic nonpulsatile blood flow in an alive, awake animal 34-day survival. Trans ASAIO 1980;26:251-255.
15. Golding LR, Murakami G, Harasaki H, et al. Chronic nonpulsatile blood flow. Trans ASAIO 1982;28:81-85.
16. Yada I, Golding LR, Harasaki H, et al. Physiological studies of nonpulsatile blood flow in chronic model. Trans ASAIO 1983;29:520-525.
17. DeVries WC. The permanent artificial heart: Four case reports. J Am Medcial Association 1988;259:849-859.
18. Nose Y. Development of rotary blood pump technology: Past, present, and future. Artificial Organs 2000;24(6):412-420.
19. Schuder JC, Gold JH, Stephenson HE. An inductively coupled RF system for the transmission of 1 KW of power through the skin. IEEE Trans BioMed Engr 1971;BME-18.
20. Mussivand T. Mechanical circulatory devices for the treatment of heart failure. J Card Surg 1999;13:218-228.
21. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Annals Surg 1995;222(3):327-338.
22. McCarthy PM, Smedira NO, Vargo RL, et al. One hundred patients with the HeartMate left ventricular assist device: Evolving concepts and technology. J Thorac Cardiovasc Surg 1998;115:904-12.
23. Banayosy EL, Arusoglu L, Kizner L, et al. Novalor left ventricular assist system versus HeartMate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: A prospective study. J Thorac Cardiovasc Surg 2000;119:581-7.
24. Minami K, EI-Banayosy A, Sezai A, et al. Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor and HeartMate for bridging to heart transplantation. Artifical Organs 2000;24(6):421-426.
25. Wieselthaler GM, Schima H, Hiesmayr M, et al.: First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation; Circulation. 2000; 101: 356-359.
26. th Congress of ISRP, September 7-9, Aachen, Germany.
27. Jarvik R: Patient adjusted manual control of Jarvik 2000 heart; 8th Congress of ISRP, September 7-9, Aachen, Germany.
28. th Congress of ISRP, September 7-9, Aachen, Germany.
29. Takatani S, Koyanagi H, Nogawa M, et al.: Ultracompact, high-performance, completely implantable permanent electromechanical total artificial heart. Heart Replacement Artificial Heart 1998;6:8-14.
30. Inamoto T, Iijima T, Honda N, et al.: Development of a motor driven total artificial heart: Evaluation of control drive mode. Jpn J Artificial Organs 1998;27(1):41-45.
31. Honda N, Inamoto T, Nogawa M, et al.:Ultracompact, completely implantable, permanent use electromechanical ventricular assist device and total artificial heart. Artificial Organs 1999; 23(3):253-261.
32. Takatani S, Nakamura M, Ouchi K,et al.: Ultracompact, completely implantable electro-mechanical permanent TAH. Heart Replacement: Artificial Heart 7, 2000 (in press).
33. Shiono, M, Noon, GP, Hess, KR, et al.: Anatomic constraints for a total artificial heart in orthotopic heart transplant recipients. J Heart Lung Transplant 1994;13:250-262.
34. Honda N, Egawa K, Inamoto T, et al.: Development of a permanent use totally impantable, ultracompact motor driven ventricular assist device and its evaluation. Jpn J of Artificial Organs 1999;28(1):37-42.
35. Honda N, Nogawa M, Takatani S: Development of a ultracompact, totally implantable ventricular assist device-Toward animal experiment. Jpn J Artificial Organs 2000; 29(1):42-46.
36. Takatani S, Nakamura M, Ouchi K, et al.: Ultracompact, completely implantable electro-mechanical pulsatile VAD. Heart Replacement: Artificial Heart 7, 2000 (in press).
37. Iijima T, Inamoto T, Nogawa M, et al.: Control of the centrifugal pump based on the motor motor current. Artificial Organs 1997;21(7):655-660.
38. Yuhki A, Hatoh E, Takatani S. Detection of the suction and regurgitation of the implantable centrifugal pump based on the motor current waveform analysis and its application to optimization of pump flow. Artificial Organs 1999; 23(6):532-537.
39. Yuhki A, Hatoh E, Nogawa M et al.: Development a tri-pod supported seal-less centrifugal blood pump. Jpn J of Artificial Organs 2000(in press).
40. Yuhki A, Nogawa M, Takatani S: Development of a compact, seal-less, tri-pod supported, magnetically driven centrifugal blood pump; Artificial Organs 2000 ;24(6):501-505.